Japan Tissue Engineering Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-734.75	-234	147	-725	-494
Depreciation & Amortization	157.38	158	134	131	124
Loss (Gain) From Sale of Assets	-	10	130	-	-
Asset Writedown & Restructuring Costs	43.33	-	-	-	-
Loss (Gain) From Sale of Investments	150	-	-	-	-
Other Operating Activities	-0.8	-27	-3	-2	-1
Change in Accounts Receivable	47.61	14	-32	-79	325
Change in Inventory	-53.5	46	9	-50	16
Change in Accounts Payable	-2.39	-4	-23	14	-114
Change in Other Net Operating Assets	-94.91	-111	-88	89	-81
Operating Cash Flow	-488.02	-148	274	-622	-225
Capital Expenditures	-74.65	-76	-196	-149	-103
Sale (Purchase) of Intangibles	-3.05	-17	-77	-26	-14
Investment in Securities	300	-150	-100	1,300	-
Other Investing Activities	30.73	11	131	-1	1
Investing Cash Flow	253.04	-232	-242	1,124	-116
Miscellaneous Cash Flow Adjustments	0	-	-1	-1	-1
Net Cash Flow	-234.98	-380	31	501	-342
Free Cash Flow	-562.67	-224	78	-771	-328
Free Cash Flow Margin	-25.78%	-9.12%	3.10%	-37.94%	-15.60%
Free Cash Flow Per Share	-13.86	-5.52	1.92	-18.98	-8.08
Cash Income Tax Paid	-1.05	27	3	3	3
Levered Free Cash Flow	-396.68	-185.75	-82.38	-549	-70.25
Unlevered Free Cash Flow	-396.68	-185.75	-82.38	-549	-70.25
Change in Working Capital	-103.18	-55	-134	-26	146